OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 71 filers reported holding OYSTER PT PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,146,000 | +24.0% | 1,805,387 | -4.4% | 0.04% | +17.1% |
Q2 2022 | $8,180,000 | -64.3% | 1,889,096 | -4.1% | 0.04% | -61.5% |
Q1 2022 | $22,922,000 | -40.3% | 1,969,222 | -6.3% | 0.09% | -40.5% |
Q4 2021 | $38,372,000 | +547.6% | 2,101,441 | +320.3% | 0.15% | +488.5% |
Q3 2021 | $5,925,000 | – | 500,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 2,768,586 | $15,559,000 | 8.54% |
NEA Management Company, LLC | 5,925,287 | $33,300,000 | 1.66% |
KPCB XIV Associates, LLC | 367,987 | $2,068,000 | 1.61% |
Paradigm Biocapital Advisors LP | 1,648,316 | $9,264,000 | 1.24% |
Telemark Asset Management, LLC | 777,026 | $4,367,000 | 0.69% |
COWEN AND COMPANY, LLC | 509,794 | $2,865,000 | 0.27% |
RTW INVESTMENTS, LP | 2,044,312 | $11,489,000 | 0.26% |
Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $5,843,000 | 0.12% |
Wildcat Capital Management, LLC | 36,847 | $207,000 | 0.08% |
ACT CAPITAL MANAGEMENT, LLC | 8,500 | $48,000 | 0.07% |